When is FOMO going to hit? Amicus has seen the data and has helped DMX gain a very low bar for approval from the FDA. Amicus are obviously tight with the FDA. Now, as Nina has said, they don’t know if DMX200 has just been better than a placebo or it’s smashed it out of the park. If it’s a home run in Q3 CY 2025, good luck getting into this stock at less than a $3 handle come September.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
51.0¢ |
Change
0.010(2.00%) |
Mkt cap ! $300.9M | |||
| Open | High | Low | Value | Volume |
| 51.0¢ | 52.5¢ | 50.0¢ | $1.131M | 2.223M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 37477 | 51.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.0¢ | 26076 | 3 |
View Market Depth
| Last trade - 16.10pm 19/06/2025 (20 minute delay) ? |
| DXB (ASX) Chart |